However, anti-BCMA-CAR2 and anti-BCMA-CAR3 T cells exhibited specific dose-dependent killing of BCMA-expressing MM cells, KMS-12-PE, and NCI-H929 cells (Fig. 4A, B). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.